IDiyas

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

Jeffrey A Dodge

USPTO Granted Patents = 74


Average Co-Inventor Count = 2.2

ph-index = 13

Forward Citations = 494(Granted Patents)

Forward Citations (Not Self Cited) = 478(Oct 12, 2025)


Inventors with similar research interests:


Company Filing History:

goldMedal74 out of 4,442 
 
Eli Lilly and Company
 patents

Years Active: 1995-2013

Loading Chart...
Loading Chart...
74 patents (USPTO):
1. 8476300 - Selective estrogen receptor modulator for the treatment of osteoarthritis (2013-07-02),
2. 8217032 - Selective estrogen receptor modulators for the treatment of vasomotor symptoms (2012-07-10),
3. 7585977 - Selective estrogen receptor modulators containing a phenylsulfonyl group (2009-09-08),
4. 7501441 - Naphthyl compounds, intermediates, processes, compositions, and methods (2009-03-10),
5. 7462647 - Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators (2008-12-09),
6. 7217734 - Substituted benzopyrans as selective estrogen receptor-beta agonists (2007-05-15),
7. 7125840 - Substituted dipeptides as growth hormone secretagogues (2006-10-24),
8. 6992097 - Growth hormone secretagogues (2006-01-31),
9. 6828331 - Growth hormone secretagogues (2004-12-07),
10. 6723739 - Glucopyranoside benzothiophenes (2004-04-20),
11. 6703407 - Benzofuran compounds, compositions, and methods (2004-03-09),
12. 6639076 - Growth hormone secretagogues (2003-10-28),
13. 6630508 - Substituted benzopyrans as selective estrogen receptor &bgr; agonists (2003-10-07),
14. 6608090 - Benzothiophenes with novel basic side chains (2003-08-19),
15. 6509356 - 1-(4-(Substituted alkoxy)benzyl)naphthalene compounds having estrogen inhibitory activity (2003-01-21),

Title: Unveiling the Innovative Path of Jeffrey A Dodge in Pharmaceutical Science

Introduction:

Jeffrey A Dodge is a prominent inventor based in Indianapolis, IN, with a remarkable track record in the field of pharmaceutical innovation. His dedication and ingenuity have led to the successful development of numerous groundbreaking inventions, making him a valuable asset in the industry.

Latest Patents:

Jeffrey A Dodge's latest patents showcase his expertise in creating novel solutions for the medical field. One of his recent inventions includes a Selective estrogen receptor modulator for the treatment of osteoarthritis, offering a promising approach to managing this debilitating condition. Additionally, his work on Selective estrogen receptor modulators for the treatment of vasomotor symptoms highlights his commitment to advancing women's health around menopause.

Career Highlights:

Currently employed at Eli Lilly and Company, Jeffrey A Dodge has contributed significantly to the company's research and development efforts. With an impressive portfolio of 74 patents to his name, he continues to drive innovation in the pharmaceutical sector and improve the quality of healthcare worldwide.

Collaborations:

Throughout his career, Jeffrey A Dodge has collaborated with esteemed professionals in the field, including Henry U Bryant and Charles Willis Lugar, III. These partnerships have not only enriched his work but also resulted in the successful realization of groundbreaking inventions that have the potential to revolutionize the industry.

Conclusion:

In conclusion, Jeffrey A Dodge stands as a beacon of innovation in the realm of pharmaceutical science. His passion for discovery, coupled with his relentless pursuit of excellence, has cemented his reputation as a trailblazer in the field. As he continues to push the boundaries of possibility, the future holds even more revolutionary inventions from this visionary inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…